This announcement is a separate document:
北京国枫律师事务所关于中源协和细胞基因工程股份有限公司2024年第一次临时股东大会的法律意见书
Legal Opinion of Beijing Guofeng Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.